ImmuneWorks has a lung transplant therapy in the works
MedCity News has partnered with BioCrossroads to provide coverage focused on Indiana’s next generation of growth and innovation in life sciences. Indianapolis startup ImmuneWorks is developing drugs to treat lung transplant patients, idiopathic pulmonary fibrosis and other fibrotic lung diseases. The 8-year-old company was founded by two researchers at the Indiana University School of Medicine […]